Real-time enrollment status for this gastric adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:49 AM UTC
| NCT Number | NCT05365581 |
| Recruiting Status | Recruiting |
| Condition | Gastric Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 398 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of August 28, 2026: Clinical trial NCT05365581 is currently recruiting participants. This phase1 study for gastric adenocarcinoma is actively seeking new participants at 13 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05365581 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05365581 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.